Calliditas Therapeutics AB (publ)

OM:CALTX Rapporto sulle azioni

Cap. di mercato: SEK 11.2b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Calliditas Therapeutics Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Renee Aguiar-Lucander

Amministratore delegato

SEK 18.4m

Compenso totale

Percentuale dello stipendio del CEO36.6%
Mandato del CEO7.4yrs
Proprietà del CEOn/a
Durata media del management3.6yrs
Durata media del Consiglio di amministrazioneless than a year

Aggiornamenti recenti sulla gestione

Recent updates

Analysts Have Lowered Expectations For Calliditas Therapeutics AB (publ) (STO:CALTX) After Its Latest Results

Feb 24
Analysts Have Lowered Expectations For Calliditas Therapeutics AB (publ) (STO:CALTX) After Its Latest Results

Health Check: How Prudently Does Calliditas Therapeutics (STO:CALTX) Use Debt?

Jan 12
Health Check: How Prudently Does Calliditas Therapeutics (STO:CALTX) Use Debt?

Market Might Still Lack Some Conviction On Calliditas Therapeutics AB (publ) (STO:CALTX) Even After 42% Share Price Boost

Dec 22
Market Might Still Lack Some Conviction On Calliditas Therapeutics AB (publ) (STO:CALTX) Even After 42% Share Price Boost

Is Calliditas Therapeutics (STO:CALTX) Weighed On By Its Debt Load?

Sep 22
Is Calliditas Therapeutics (STO:CALTX) Weighed On By Its Debt Load?

What You Need To Know About The Calliditas Therapeutics AB (publ) (STO:CALTX) Analyst Downgrade Today

Aug 19
What You Need To Know About The Calliditas Therapeutics AB (publ) (STO:CALTX) Analyst Downgrade Today

Investors Don't See Light At End Of Calliditas Therapeutics AB (publ)'s (STO:CALTX) Tunnel And Push Stock Down 26%

May 26
Investors Don't See Light At End Of Calliditas Therapeutics AB (publ)'s (STO:CALTX) Tunnel And Push Stock Down 26%

Is Calliditas Therapeutics (STO:CALTX) Using Debt Sensibly?

Feb 24
Is Calliditas Therapeutics (STO:CALTX) Using Debt Sensibly?

Health Check: How Prudently Does Calliditas Therapeutics (STO:CALTX) Use Debt?

Nov 25
Health Check: How Prudently Does Calliditas Therapeutics (STO:CALTX) Use Debt?

Calliditas Therapeutics AB (publ) (STO:CALTX) Analysts Just Slashed This Year's Revenue Estimates By 19%

Aug 24
Calliditas Therapeutics AB (publ) (STO:CALTX) Analysts Just Slashed This Year's Revenue Estimates By 19%

Is Calliditas Therapeutics (STO:CALTX) Using Too Much Debt?

Aug 03
Is Calliditas Therapeutics (STO:CALTX) Using Too Much Debt?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Renee Aguiar-Lucander rispetto agli utili di Calliditas Therapeutics?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-SEK 480m

Mar 31 2024n/an/a

-SEK 525m

Dec 31 2023SEK 18mSEK 7m

-SEK 466m

Sep 30 2023n/an/a

-SEK 451m

Jun 30 2023n/an/a

-SEK 292m

Mar 31 2023n/an/a

-SEK 393m

Dec 31 2022SEK 13mSEK 6m

-SEK 412m

Sep 30 2022n/an/a

-SEK 628m

Jun 30 2022n/an/a

-SEK 608m

Mar 31 2022n/an/a

-SEK 576m

Dec 31 2021SEK 11mSEK 5m

-SEK 500m

Sep 30 2021n/an/a

-SEK 452m

Jun 30 2021n/an/a

-SEK 600m

Mar 31 2021n/an/a

-SEK 501m

Dec 31 2020SEK 7mSEK 3m

-SEK 433m

Sep 30 2020n/an/a

-SEK 286m

Jun 30 2020n/an/a

-SEK 198m

Mar 31 2020n/an/a

-SEK 54m

Dec 31 2019SEK 4mSEK 3m

-SEK 33m

Sep 30 2019n/an/a

-SEK 54m

Jun 30 2019n/an/a

-SEK 35m

Mar 31 2019n/an/a

-SEK 136m

Dec 31 2018SEK 4mSEK 2m

-SEK 132m

Compensazione vs Mercato: La retribuzione totale di Renee ($USD 1.77M ) è superiore alla media delle aziende di dimensioni simili nel mercato Swedish ($USD 754.57K ).

Compensazione vs guadagni: La retribuzione di Renee è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Renee Aguiar-Lucander (62 yo)

7.4yrs

Mandato

SEK 18,367,000

Compensazione

Ms. Renee Aguiar-Lucander serves as Director at Genkyotex SA since November 2020. Ms. Aguiar-Lucander has been Chief Executive Officer of Calliditas Therapeutics AB (publ) since May 2017. Prior to joining...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Renee Aguiar-Lucander
Chief Executive Officer7.4yrsSEK 18.37mNessun dato
Fredrik Johansson
Chief Financial Officer7.2yrsNessun dato0%
SEK 0
Lars Stubberud
Vice President of Technical Operations1.8yrsNessun datoNessun dato
Asa Hillsten
Head of IR & Sustainability1.8yrsNessun datoNessun dato
Brian Gorman
Group General Counsel1.8yrsNessun datoNessun dato
Sandra Frithiof
Vice President of Human Resources4.8yrsNessun datoNessun dato
Ann-Kristin Myde
Head of Clinical Development & VP of Project Management7.8yrsNessun datoNessun dato
Richard Philipson
Chief Medical Officer4.3yrsNessun datoNessun dato
Teona Johnson
Head of US Marketing3.6yrsNessun datoNessun dato
David Ferraro
Head of US Sales3.6yrsNessun datoNessun dato
Monika Tornsen
President of North Americaless than a yearNessun datoNessun dato
Christopher Ngai
Vice President of Market Accessno dataNessun datoNessun dato

3.6yrs

Durata media

49yo

Età media

Gestione esperta: Il team dirigenziale di CALTX è considerato esperto (durata media dell'incarico 3.6 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Yoshikazu Aoki
Non-Executive Directorless than a yearNessun datoNessun dato
Mark Hensley
Chairmanless than a yearNessun datoNessun dato
Jonathan Barratt
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Jürgen Floege
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Richard Lafayette
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Brad Rovin
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Vladimir Tesar
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Hérnan Trimarchi
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Masaya Etoh
Non-Executive Directorless than a yearNessun datoNessun dato
Heather Reich
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Hong Zhang
Member of Scientific Advisory Boardno dataNessun datoNessun dato

0.08yrs

Durata media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di CALTX non è considerato esperto (durata media del mandato 0.1 anni), il che suggerisce un nuovo consiglio.